Product Information
ENTACAPONE 200 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.3246 per EA under NDC 62332047831. Its NADAC has been published 220 times since Jul 20, 2022.
FDA first approved this application on Jan 4, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332047831
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ENTACAPONEApproval Type
Generic (ANDA)
FDA Application
ANDA212601FDA Approved
1/4/2022
TE Code
AB
On Market Since
1/6/2022
Pharmacological Classes
Price Statistics
The NADAC for ENTACAPONE 200 MG TABLET has been published 220 times since Jul 20, 2022, and over the history we have for it it has declined 24.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3246 per EA |
|---|---|
| All-time high | $0.4651 (Jul 12, 2023) |
| All-time low | $0.2327 (Jul 17, 2024) |
| 52-week high | $0.3628 |
| 52-week low | $0.3192 |
| Median price | $0.3686 |
| Average price | $0.3641 |
| Largest weekly change | +59.1% (Aug 21, 2024) |
| Weeks tracked | 220 |
| Tracking since | Jul 20, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ENTACAPONE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ENTACAPONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Catechol-O-Methyltransferase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENTACAPONE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENTACAPONE 200 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.3246 per EA (NDC 62332047831), effective Sep 30, 2026.
How has the price of ENTACAPONE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENTACAPONE 200 MG TABLET has declined 24.4%. It has been tracked across 220 weekly CMS publications since Jul 20, 2022.
What are the highest and lowest recorded NADAC prices for ENTACAPONE 200 MG TABLET?
Since Jul 20, 2022, the NADAC for ENTACAPONE 200 MG TABLET has ranged from a low of $0.2327 (Jul 17, 2024) to a high of $0.4651 (Jul 12, 2023), with a median of $0.3686 per EA.
Are there cheaper alternatives to ENTACAPONE 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ENTACAPONE 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ENTACAPONE 200 MG TABLET?
ENTACAPONE 200 MG TABLET (NDC 62332047831) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.